Martine Dehlinger-Kremer

Martine Dehlinger-Kremer

President of EUCROF; VP Pediatric Development Synteract (Germany)

Dr. Martine Dehlinger-Kremer is President of EUCROF, the European CRO Federation;

Vice President, Global Medical and Regulatory Affairs at SynteractHCR , a CRO with headquarters in California and 11 other offices internationally. She is also a Board member of EFGCP (European Forum for GCP).

Dr. Dehlinger-Kremer has 30 years of experience in the clinical research industry, including more than 27 years of progressively higher levels of Regulatory and Medical Affairs leadership responsibility.

Dr. Dehlinger-Kremer has contributed to the global development of numerous products, including orphan drugs and biosimilars. She has participated in more than 100 New Drug Applications (NDAs) and Marketing Authorization Applications (MAAs) globally and in numerous clinical studies across all phases.

Dr. Dehlinger-Kremer has served as Chair of the Paediatric Working Group of EUCROF since 2008 and has influenced the standards, protocols and number of trials conducted for drugs being administered to children. Dr. Dehlinger-Kremer is chair of the EFGCP Children Medicines Working Party. Dr. Dehlinger-Kremer is also Member of Working Parties of Enpr-EMA, the European Network of Paediatric Research at the European Medicines Agency.

Dr Dehlinger-Kremer was Named One of PharmaVOICE 100’s Most Inspiring People in Life Sciences (Industry leader recognized for impact, experience and advocacy in clinical research) in August 2015.